Table 4.
Brazil (0.46) | China (0.46) | Germany (0.50) | Italy (0.50) | Korea (0.46) | USA (0.50) | Total | |
---|---|---|---|---|---|---|---|
Survey year | 2014–2016 | 2009 | 2000–2007 | 2008–2010 | 2011–2012 | 2015–2018 | 2000–2018 |
Sample size | 824 | 749 | 6810 | 724 | 152 | 360 | 9619 |
Boys (%) | 463 (56.2) | 411 (54.9) | 3578 (52.5) | 395 (54.6) | 105 (69.1) | 179 (49.7) | 5131 (53.3) |
Age (years) | 6–18 | 7–17 | 6–18 | 6–18 | 12–15 | 12–18 | 6–18 |
Cardiometabolic risk factors clustering based on IDF criteria, OR (95% CI) | |||||||
≥ 2 | 3.49 (0.99–12.30) | 4.02 (2.15–7.51) | 3.20 (2.47–4.14) | 5.19 (2.06–13.08) | 5.09 (2.05–12.64) | 3.34 (1.74–6.42) | 3.70 (3.09–4.43) |
≥ 3 | 3.39 (0.21–54.52) | 2.33 (0.39–14.07) | 4.04 (1.97–8.29) | 5.42 (0.71–41.52) | 2.62 (0.31–22.52) | 7.83 (0.90–67.81) | 5.40 (3.34–8.74) |
Cardiometabolic risk factors clustering based on NCEP criteria, OR (95% CI) | |||||||
≥ 2 | 3.23 (1.89–5.55) | 2.12 (1.30–2.46) | 2.99 (2.39–3.74) | 3.46 (2.08–5.76) | 4.78 (1.86–12.28) | 3.28 (1.60–6.74) | 4.03 (3.48–4.66) |
≥ 3 | 7.16 (1.77–28.94) | 2.08 (0.49–8.80) | 6.18 (3.86–9.90) | 9.13 (2.19–38.15) | 5.73 (0.70–46.64) | 6.06 (0.67–54.86) | 8.23 (5.87–11.55) |
Abbreviations CI Confidence interval, IDF International Diabetes Federation, NCEP National Cholesterol Education Program, OR Odds ratio, WHtR Waist-to-height ratio. OR (95%CI) was calculated using < 2 cardiometabolic risk factors clustering as the reference group
Mutivariate logistic regression models were adjusted for sex and age in each population, and additionally adjusted for survey year in total population